4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000033
Chief Executive Officer sold 1,729 shares at $41.30 ($71,408)
From the SEC's structured data for this filing
Trades in this filing
Klein Lawrence Otto · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-16 | Sale : show line 1 in the form | −1,729 | $41.30 | $71,408 | 927,309 | D |
| Open-market sales · 1,729 sh · avg $41.30 · $71,408 | ||||||
Loading xslF345X05/form4.xml…